跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAMCEVI 42 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CAMCEVI 42 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Approved
STANDARD
CAMCEVI 42 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Accord Healthcare S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 13, 2022
Approval ID
e60112c7f6743882
Company
Accord Healthcare S.L.U.
Type
Standard
Approval Details
Approval Id
e60112c7f6743882
Drug Cima Aemps Name
CAMCEVI 42 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Register Number
1221647001
Holder Company Name
Accord Healthcare S.L.U.
Marketing Company Name
Accord Healthcare S.L.U.
Holder Company Detail Path
/organization/accord-healthcare-sl
Marketing Company Detail Path
/organization/accord-healthcare-sl
Authorization Date
2022-06-13
Dosage Form
SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Dose
42 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Accord Healthcare S.L.U.
Company Detail Path
/organization/accord-healthcare-sl
Company Information
Pharmaceutical Company Name
ACCORD HEALTHCARE SL
Country Name
Spain
City Name
barcelona,barcelona,country_es
Address
CALLE MOLL BARCELONA (WORLD TRADE CENTER EDIF. ESTE), S/N
Active Ingredients
LEUPRORELINA MESILATO
48,05 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 13, 2022
Approval ID
e60112c7f6743882
Type
Standard
Back to CIMA-AEMPS Approvals